Insider · CIK 0001518575
Brownlie Keith L
Reports to the SEC for 5 companies · HAMPTON, NJ
Transactions
35
Companies
5
Filings
18
CIK
0001518575
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-25 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2025-06-05 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2024-06-13 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2023-06-15 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2022-06-16 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2021-06-17 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2020-06-18 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2019-06-19 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2019-02-13 | PHIOPhio Pharmaceuticals Corp.A Award | — |
| 2018-09-27 | SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award | — |
| 2018-08-01 | PHIOPhio Pharmaceuticals Corp.A Award | — |
| 2018-06-13 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2017-06-15 | CLDXCelldex Therapeutics, Inc.A Award | — |
| 2017-06-15 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2017-06-15 | CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2017-06-08 | SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award | — |
| 2017-02-01 | PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award | — |
| 2016-06-16 | SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award | — |
| 2016-02-10 | PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award | — |
| 2015-06-18 | SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award | — |
| 2015-06-01 | PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award | — |
| 2015-04-09 | SNGXSOLIGENIX, INC. · Common Stock WarrantM Exercise/Conversion | — |
| 2015-04-09 | SNGXSOLIGENIX, INC.M Exercise/Conversion | +$8,714.46 |
| 2013-10-10 | Vyant Bio, Inc.Stock Option (right to buy)A Award | — |
| 2013-10-10 | Vyant Bio, Inc.Stock Option (right to buy)A Award | — |
| 2013-09-27 | SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award | — |
| 2013-08-12 | IMMUNE PHARMACEUTICALS INCA Award | — |
| 2013-06-25 | SNGXSOLIGENIX, INC.P Purchase | +$20K |
| 2013-06-25 | SNGXSOLIGENIX, INC. · Common Stock WarrantsP Purchase | — |
| 2013-06-07 | PHIOPhio Pharmaceuticals Corp. · Stock Option (right to buy)A Award | — |
| 2012-06-21 | SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award | — |
| 2012-06-21 | IMMUNE PHARMACEUTICALS INCRestricted Stock UnitsA Award | — |
| 2011-06-22 | SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award | — |
| 2011-06-14 | IMMUNE PHARMACEUTICALS INCRestricted Stock UnitsA Award | — |
| 2011-04-27 | IMMUNE PHARMACEUTICALS INCStock Option (right to buy)A Award | — |
Recent filings
- 4Brownlie Keith L0001518575-26-000002SEC(opens sec.gov)
- 4Brownlie Keith L0001415889-25-016216SEC(opens sec.gov)
- 4Brownlie Keith L0001415889-24-017151SEC(opens sec.gov)
- 4Brownlie Keith L0001415889-23-010038SEC(opens sec.gov)
- 4Brownlie Keith L0001415889-22-006700SEC(opens sec.gov)
- 4Brownlie Keith L0001179110-21-006892SEC(opens sec.gov)
- 4Brownlie Keith L0001179110-20-007589SEC(opens sec.gov)
- 4Brownlie Keith L0001179110-19-007970SEC(opens sec.gov)
- 4Brownlie Keith L0001209191-19-010825SEC(opens sec.gov)
- 4Brownlie Keith L0001213900-18-013220SEC(opens sec.gov)
- 4Brownlie Keith L0001209191-18-045458SEC(opens sec.gov)
- 4Brownlie Keith L0001179110-18-008562SEC(opens sec.gov)
- 4Celldex Therapeutics, Inc.0001179110-17-009169SEC(opens sec.gov)
- 4SOLIGENIX, INC.0001213900-17-006383SEC(opens sec.gov)
- 4RXi Pharmaceuticals Corp0001209191-17-007738SEC(opens sec.gov)
- 4SOLIGENIX, INC.0001213900-16-014389SEC(opens sec.gov)
- 4RXi Pharmaceuticals Corp0001209191-16-098337SEC(opens sec.gov)
- 4SOLIGENIX, INC.0001213900-15-004606SEC(opens sec.gov)
Companies
Address
C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220
HAMPTON, NJ, 08827